It has been suggested that brachyury inhibits the cell cycle by downregulating cyclin D (CCND1), RB (RB1) and CDKN1A (P21), ultimately decreasing the susceptibility of tumor cells to cytotoxic therapies (Huang et al., 2013). Here, RB1 is linked to neoplasm.